Coronavirus

Federal advisory panel to meet Wednesday on J&J vaccine

A federal advisory panel will meet Wednesday to debate whether and how Johnson & Johnson's Covid-19 vaccine should continue to be used in the U.S., following reports of rare but severe blood clots among a few recipients.